Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research

Lactobacillus reuteri DSM 17938 and Reduced Crying Duration

Research synthesisLow evidenceMixed effect size3 studies · 2 beneficial · 1 neutral · 0 harmful

Across 3 studies, 2 reported beneficial effects on reduced crying duration, with 1 large effect (systematic review of 2,242 infants with colic, WMD -51.3 h [CI95% -72.2 to -30.5 h], p=0.0001) and 1 small significant effect (review of breastfed infants). The remaining study (RCT, n=89 neonates on antibiotics) found no statistically significant benefit. The median study duration was 42 days. The predominant effect direction is beneficial, but effect sizes are mixed (small to large). Most evidence pertains to infants with colic.

  • Studied populations: infants with infantile colic; breastfed infants

Caveats: Evidence base is small (only 3 studies) — conclusions should be considered preliminary. The single largest study (systematic review, n=2,242) reports a large beneficial effect, but it is a meta-analysis that may include overlapping data. One recent RCT (2024) in antibiotic-exposed neonates found no significant benefit, suggesting effectiveness may depend on the specific population. One study did not report a sample size.

Generated Jun 11, 2026
Doses used in studies
  • CFU/day: 100 million–1 billion (median 100 million, IQR 100 million550 million) 3 studies
Time to effect
Median: 6 weeks · IQR 6 weeks6 weeks · Range 6 weeks6 weeks — Reported in 1 of 3 studies
3 of 3 papers
Back to top